BioengineeringbioRxivPreprint
Translational Opportunity of Engineered IFNγ-eEVs Through Targeted Inhibition of JAK/STAT1 Signaling, Mimicking IVIg Therapy
Kylie E Preihs, Kübra Karagoz, Claire R Shuey…·My G Mahoney
This paper identifies EV-associated cytokines as mediators of IVIg activity, showing that engineered IFNγ-eEVs can suppress IFNγ signaling through context-dependent mechanisms.
DOI 10.64898/2026.04.29.721601